Progress in cancer therapies over the past few years has been very promising, although all of the newest technologies still have to run the twin gauntlets of commercialization and FDA approval. This article from the Star-Telegram illustrates progress towards curing lung cancer - one of the most deadly cancers - by causing the body to attack cancerous cells. These new types of cancer therapy depend on advancing knowledge of biochemical and cellular processes, greatly accelerated by bioinformatics. From one of the trial participants: "I would tell anyone who gets the same diagnosis to stretch as far as they can and go to any kind of experimental therapy. If I hadn't done that, I wouldn't be here now."